Impersonal research, traced to filings. An evidence-first read of whether Monolithic Power Systems's move up the value chain is real, well-stewarded, and still underappreciated — the same for every reader, from SEC EDGAR 10-K + 8-K filings. This is not personalized advice or a recommendation to any specific person. As of 24 Jul 2026. Disclosures.
How it scores
Seven dimensions, 0–5 — the baseline everyone has (28%) plus the revealed-behaviour Analysis Bridge (72%). The method →
Baseline
Analysis Bridge
The evidence, dimension by dimension
Execution (do-side)
4/5Strong operating execution: +26.4% revenue growth broad-based across five of six end markets, OPM expanding to 26.1%, gross margin defended at 55.2% through a downcycle, R&D scaled to $382M, headcount up to 4,501. Fabless model converts to cash cleanly. Marked down from 5 by a genuine execution defect in the finance function (tax-accounting restatement + material weakness) and a CFO transition (Blegen departing at filing, interim CFO Rob Dean).
Say/do credibility
3/5Say/do is mixed. Do-side franchise promises delivered strongly: diversification (all six markets grew; total +26.4% even as enterprise-data/AI declined -2%), above-industry margins (OPM 24.4%->26.1%), and a decade-long structural climb ($333M/12.3% OPM in 2015 -> $2.79B/26.1% in 2025) — this is the credible core. But two credibility drags weigh the ledger: (1) a material weakness + restatement of FY2024 and 2025 interims for deferred-tax accounting, with ICFR judged NOT effective at both year-ends — a delivered miss on the reliable-reporting promise; and (2) a securities class action (Waterford Twp. v. MPWR, W.D. Wash., filed 2025-02-04) plus consolidated derivative suits alleging misstatements about the business (notably around AI/enterprise-data demand). Track record on the commercial franchise is excellent; track record on control/disclosure hygiene is currently impaired, so guidance should be weighted down until the weakness is remediated.
Strategy — IP & partnerships
5/5Best-in-class specialty-analog franchise. Proprietary BCD-style process AND packaging technologies developed in-house and installed on foundry-partner equipment under MPS control (unusual for a fabless company) — this is the 'silicon-plus / module' value-migration engine. 2,231 patents/applications (654 U.S. issued) out to 2045, trade-secret process moat, >10-year product life cycles, and deep system-level design-in create high switching costs. Positioned in structurally growing content-per-system markets (AI/enterprise data, automotive ADAS, comms optical). Clear, funded move up the value chain from discrete components to integrated modules.
Governance & stewardship
2/5Weakest dimension. Material weakness in ICFR unremediated at Dec 31, 2025; restatement of FY2024 + three 2025 quarters; ongoing securities class action and consolidated shareholder derivative suits against the CEO/executives/directors alleging fiduciary breaches. Founder-CEO Michael Hsing is also Board Chairman (combined roles / concentrated founder control). CFO departure at filing with only an interim (Corporate Controller) replacement amid an active accounting weakness is a governance red flag. Mitigants: long-tenured stable executive team, independent NCG committee with cybersecurity oversight, dividend + buyback discipline, clean prior audit history — so not disqualifying, but clearly impaired this cycle.
Margins over the cycle
Operating margin and return on capital across the last decade of SEC filings. A structural climb up the value chain holds its gains through the down-cycle; a commodity name gives them back. Structural vs cyclical →
From SEC EDGAR XBRL.
The say/do credibility ledger
What management promised, versus what the filings show they delivered — the single largest weight in the read.
| Promise | When | Status | What the filings show |
|---|---|---|---|
| Diversify revenue beyond any single large customer / end market and 'grow our sales in a diversified way across regions' (durability vs. a single-customer spike) | 10-K FY2025 Item 1 (recurring long-standing MPS strategy) | Delivered | FY2025 growth was broad-based across all six end markets, not a single-customer/enterprise-data spike. Storage & Computing +46.0%, Automotive +43.1%, Communications +36.8%, Industrial +35.3%, Consumer +26.3%; Enterprise Data actually declined -2.0% yet total revenue still grew +26.4%. End-market mix is balanced (Storage/Computing 26.3%, Enterprise Data 25.2%, Automotive 21.2%). No single direct customer >10% of revenue; concentration is via distributors, not one OEM. 10-K FY2025, Item 7 MD&A (Revenue by end market); Item 1 (Customers) |
| Operate at above-average industry performance / defend high margins through mix shift up the value chain (integration, module content, process IP) | 10-K FY2025 Item 1 / Item 7 Overview | Delivered | FY2025 OPM 26.1% (up from 24.4% FY2024), gross margin 55.2%, recovering from the FY2023-24 downcycle. 11-year OPM path (12.3% FY2015 -> 26.1% FY2025) and revenue CAGR from $333M (2015) to $2,790M (2025) show a structural climb, not a one-year cycle top. Gross margin held ~55-56% across the downturn, evidencing pricing power / franchise mix rather than commodity cyclicality. 10-K FY2025, Item 7 (Cost of Revenue and Gross Margin); baseline fundamentals FY2015-2025 (OPM/ROCE series) |
| AI / enterprise-data and data-center power content wins would be a growth driver | prior-year commentary; 10-K FY2025 Item 1 (Enterprise Data = AI systems) | In progress | Enterprise Data (cloud/CPU servers + AI) grew from 17.7% of revenue (2023) to 32.5% (2024) but slipped to 25.2% (2025), declining -2.0% in dollars YoY. Real content-win franchise, but lumpy/customer-timing-dependent; the AI power story is proven but not yet a smooth compounder, and 2025 leadership was storage/computing and automotive rather than enterprise data. 10-K FY2025, Item 7 (Revenue by end market 2023-2025); Item 1 (Enterprise Data applications) |
| Maintain reliable financial reporting / effective internal controls | ongoing SEC reporting obligation | Missed | Company restated FY2024 audited financials and Q1-Q3 2025 financials for mis-accounting of deferred income taxes tied to a one-time foreign tax incentive; concluded internal control over financial reporting was NOT effective at Dec 31, 2024 AND Dec 31, 2025 (material weakness identified, not yet remediated). An 8-K under Item 4.02 (non-reliance on prior financials) was filed 2026-02-27. This is a delivered-negative on the say/do ledger. 10-K FY2025, Item 7 risk discussion (restatement / material weakness); Item 9A; 8-K 2026-02-27 Item 4.02 |
| Return capital to shareholders (buyback + dividend) | 2025-02 (Board approval) | In progress | $500M buyback authorized Feb 2025 but only ~$6.6M (~8,000 shares) repurchased in FY2025 (~$493M still available), so execution has lagged the authorization; quarterly dividend program maintained and paid. Capital-return commitment real but buyback deployment minimal so far. 10-K FY2025, Item 5 (Issuer Purchases; Dividend Policy) |
Triangulation chain
A real migration lights up all five: stated → approved → funded → permitted → protected. An announced-only one stalls early.
Stated strategy is to move up the value chain from discrete power components to highly-integrated, single-chip and module-level power-management solutions built on proprietary process/packaging IP, and to diversify revenue across six end markets and regions. 'We plan to continue to introduce new products within our existing product families, as well as new, innovative products that expand our market' and revenue growth depends on the ability to 'enter new market segments, obtain design wins, grow our sales in a diversified way across regions, expand our customer base.' (10-K FY2025, Item 1 Business (General; Product Families))
Board-level capital-allocation actions approved: February 2025 Board approved a $500.0M stock repurchase program (through Feb 2028) and a quarterly cash dividend program, signalling confidence in the franchise cash flows. R&D directed by the board at three targeted areas including proprietary analog power processes and packaging ('key strategic components to our future growth'). (10-K FY2025, Item 5 (Issuer Purchases; Dividend Policy); Item 1 (R&D))
Self-funded from a fabless model with structurally high cash generation: FY2025 revenue $2,790.5M (+26.4% YoY), operating income $728.6M (26.1% OPM), gross margin 55.2%. R&D spend rose to $382.3M (13.7% of revenue). No debt drawdown needed; capex-light fabless approach 'limit[s] our capital expenditures and fixed costs.' Only ~$6.6M of the $500M buyback used in FY2025 (dry powder retained). (10-K FY2025, Item 7 MD&A (Results of Operations; R&D); Item 5 (Issuer Purchases))
Not a permit-gated industrial; the fabless model needs foundry capacity rather than site permits. Company reports a 'diversified and adaptable supply chain' across China, Taiwan, South Korea, Singapore, Malaysia and states that through the 10-K filing date 'no restrictions or requirements [export controls/tariffs] have had a material impact on our revenue and operations.' Facilities compliant with environmental/worker-safety laws; largest Chengdu testing facilities ISO 14001/45001 certified. Capacity-securing is an explicit growth dependency (permitting analog = securing foundry capacity), which is being met. (10-K FY2025, Item 1 (Manufacturing; Government Regulations); Item 7 (Macroeconomic Conditions and Regulations))
Deep IP moat: 2,231 patents/applications issued or pending as of Dec 31, 2025 (654 U.S. issued), expiring through Dec 2045, plus proprietary BCD-style process and packaging technologies held as trade secrets and installed on foundry-partner equipment under MPS control ('in contrast to many fabless semiconductor companies... we have developed our own proprietary process and packaging technologies'). Long >10-year product life cycles and deep system-level design-in create high switching costs. (10-K FY2025, Item 1 (Patents and Intellectual Property; Manufacturing; R&D))
Catalysts
- US-China export controls / tariffs and retaliatory trade measures; 92% Asia revenue concentration · 2025-2026 (ongoing)
Trade-policy escalation is the principal downside catalyst given MPS's Asia/China revenue and China-anchored (though diversified) supply chain; company states no material impact through the filing date but flags it can change quickly.
- Securities class action (Waterford Twp. Gen. Emps. Ret. Sys. v. MPWR) + consolidated derivative litigation · 2025-02-04 (filed); ongoing
Litigation and material-weakness remediation are overhangs; adverse developments or a re-restatement would pressure the stock and further impair credibility. Remediation completion would be a positive catalyst.
- Proprietary process/packaging IP portfolio (2,231 patents/applications, 654 U.S. issued, out to 2045) enabling module/silicon-plus content wins in AI power · as of 2025-12-31
Deep, long-dated IP moat sustains design-win pipeline and content-per-system growth in data-center/AI and automotive; supports durability of the high-margin franchise.
Risk flags
- governance_integrity_flag
Triggered as a caution (not a hard veto): unremediated material weakness in ICFR at Dec 31, 2025, restatement of FY2024 + three 2025 quarters (deferred-tax accounting), active securities class action + consolidated derivative litigation, and a CFO departure at filing with only an interim replacement. Reporting-integrity risk is elevated and should discount reported figures and management guidance until remediation is confirmed.
Sources
Bridged from SEC EDGAR 10-K + 8-K filings, latest 10-K filed 27 Feb 2026. Read the 10-K on SEC EDGAR → Provenance: agent-grounded-fulltext. Financials from SEC EDGAR XBRL; price from public market data.